Agios Pharmaceuticals
AGIO
#4752
Rank
A$3.19 B
Marketcap
A$53.75
Share price
-0.08%
Change (1 day)
2.95%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -A$0.72 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are A$66.04 Million. In 2025 the company made an earning of -A$0.69 Billion a decrease over its 2024 earnings that were of -A$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.72 Billion3.8%
2025 -A$0.69 Billion10.9%
2024 -A$0.62 Billion8.75%
2023 -A$0.57 Billion0.63%
2022 -A$0.57 Billion2.81%
2021 -A$0.55 Billion10.58%
2020 -A$0.5 Billion-18.41%
2019 -A$0.61 Billion15.72%
2018 -A$0.53 Billion12.99%
2017 -A$0.47 Billion59.61%
2016 -A$0.3 Billion69.32%
2015 -A$0.18 Billion119.28%
2014 -A$78.48 Million39.22%
2013 -A$56.37 Million69.1%
2012 -A$33.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.35 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.11 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.51 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-A$0.21 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.45 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA